Selexys Pharmaceuticals
Oklahoma City, US · Delaware corporation · 1 known investors
Find your way into Selexys Pharmaceuticals
Founders & leadership
SR
Scott Rollins, Ph.D.Founder
RM
Rodger McEver, M.D.Named on SEC filing
Board
PJ
Philip Jones, M.D.Board director
TF

DK
David KeiserBoard director
Investors · 1
MPM BioImpactreportedBoston · $1M – $15M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$43.2M disclosed across 1 round · 2012
▶$43.2MraisedFeb 2015 · 57 investors · BiotechnologyRule 506(b)
▶$43.2MraisedFeb 2015 · 57 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David FalconerExecutive Officer
- Philip Jones, M.D.Director
- David KeiserDirector
- Richard AlvarezExecutive Officer
- Todd FoleyDirector
- Russell RotherExecutive Officer
- Rodger McEver, M.D.Director
- Scott Rollins, Ph.D.Executive Officer, Director
- Offering amount
- $43.2M
- Amount sold
- $43.2M
- Minimum investment
- $13.2K
- Proceeds to insiders
- $4.9M
- First sale
- Sep 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Selexys Pharmaceuticals?
- Selexys Pharmaceuticals was founded by Scott Rollins, Ph.D..
- Who are Selexys Pharmaceuticals's investors?
- Selexys Pharmaceuticals's investors include MPM BioImpact.
- How much funding has Selexys Pharmaceuticals raised?
- Selexys Pharmaceuticals has disclosed $43.2M raised across 1 round.
- Where is Selexys Pharmaceuticals headquartered?
- Selexys Pharmaceuticals is headquartered in Oklahoma City, US.


